相关实验视频

Updated: Jul 9, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

最近在基于免疫基的瘤新抗原发现方面取得的进展

Wei Meng¹, Robert D Schreiber¹, Cheryl F Lichti¹

¹Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, United States; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO, United States.

Advances in immunology

|December 2, 2023

概括

瘤抗原,包括新抗原,是癌症免疫的关键. 质谱仪 (MS) 最近的进展现在可以从更小的样本中敏感检测这些新抗原,改善癌症免疫疗法研究.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
蛋白质组学是指蛋白质组学.

背景情况:

异常表达的蛋白质和新抗原驱动抗瘤免疫力.
下一代测序 (NGS) 和质谱 (MS) 已经推进了新抗原检测.
对于识别突变来说,免疫体的MS概况是至关重要的.

研究的目的:

为突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
讨论各种瘤抗原类别和识别方法.
要总结最近基于MS的新抗原检测成功.

主要方法:

使用先进的质谱 (MS) 技术用于免疫学.
采用下一代测序 (NGS) 进行新抗原发现.
分析瘤特异性免疫皮体,以识别突变.

主要成果:

新的MS技术允许从更少的细胞中检测新抗原.
通过使用各种MS技术报告了成功的瘤新抗原检测.
进步使T细胞识别新抗原的更直接的识别成为可能.

结论:

免疫类药物在特征瘤新抗原方面越来越强大.
技术改进克服了MS新抗原发现的先前局限性.
这些进展有助于开发新的癌症免疫疗法.

关键词:

免疫基因组是指免疫基因组.免疫类药物免疫类药物离子移动性光谱仪离子移动性光谱仪质谱测量质谱测量质谱测量质量测量质谱测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量新抗原是一种新抗原.这些是瘤抗原.

更多相关视频

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.